A Novel Nanocapsule Delivery System to Overcome Intestinal Degradation and Drug Transport Limited Absorption of P-glycoprotein Substrate Drugs

被引：0
|
作者：
Taher Nassar
Alona Rom
Abraham Nyska
Simon Benita
机构：
[1] The Hebrew University of Jerusalem,Department of Pharmaceutics, School of Pharmacy
[2] Tel Aviv University,Consultant in Toxicological Pathology, Sackler School of Medicine
来源：
Pharmaceutical Research | 2008年 / 25卷
关键词：
CYP3A; nanocapsules; P-gp; tacrolimus;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2019 / 2029
页数：10
相关论文
共 50 条
  • [31] Novel formulation approaches for optimising delivery of anticancer drugs based on P-glycoprotein modulation
    Bansal, Tripta
    Akhtar, Naseem
    Jaggi, Manu
    Khar, Roop K.
    Talegaonkar, Sushama
    DRUG DISCOVERY TODAY, 2009, 14 (21-22) : 1067 - 1074
  • [32] P-glycoprotein, secretory transport, and other barriers to the oral delivery of anti-HIV drugs
    Aungst, BJ
    ADVANCED DRUG DELIVERY REVIEWS, 1999, 39 (1-3) : 105 - 116
  • [33] P-glycoprotein, secretory transport, and other barriers to the oral delivery of anti-HIV drugs
    DuPont Pharmaceuticals, P.O. Box 80400, Wilmington, DE 19880-0400, United States
    Adv. Drug Deliv. Rev., 1-3 (105-116):
  • [34] Regional difference in intestinal drug absorption as a measure for the potential effect of P-glycoprotein efflux transporters
    Ashmawy, Shimaa M.
    El-Gizawy, Sanaa A.
    El Maghraby, Gamal M.
    Osman, Mohamed A.
    JOURNAL OF PHARMACY AND PHARMACOLOGY, 2019, 71 (03) : 362 - 370
  • [35] Possible roles of intestinal P-glycoprotein and cytochrome P450 3A on the limited oral absorption of irinotecan
    Yamasaki, Keishi
    Hidaka, Muneaki
    Kawano, Yohei
    Furuya, Yumiko
    Ono, Hiroshige
    Arimori, Kazuhiko
    JOURNAL OF PHARMACY AND PHARMACOLOGY, 2021, 73 (02) : 178 - 184
  • [36] Active secretion of drugs from the small intestinal epithelium in rats by P-glycoprotein functioning as an absorption barrier
    Terao, T
    Hisanaga, E
    Sai, Y
    Tamai, I
    Tsuji, A
    JOURNAL OF PHARMACY AND PHARMACOLOGY, 1996, 48 (10) : 1083 - 1089
  • [37] The P-Glycoprotein Transport System and Cardiovascular Drugs (vol 61, pg 2495, 2013)
    Wessler, J. D.
    Grip, L. T.
    Mendell, J.
    Giugliano, R. P.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 63 (20) : 2176 - 2176
  • [38] The P-Glycoprotein Transport System and Cardiovascular Drugs (vol 61, pg 2495, 2013)
    Wessler, J. D.
    Grip, L. T.
    Mendell, J.
    Giugliano, R. P.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2015, 65 (25) : 2771 - 2771
  • [39] Effects of furanocoumarins in Kampo extract-based medicines on rat intestinal absorption of CYP3A and P-glycoprotein substrate drugs in vivo
    Kazunori Iwanaga
    Kaori Arimune
    Makoto Miyazaki
    Makio Shibano
    Masahiko Taniguchi
    Kimiye Baba
    Masawo Kakemi
    Archives of Pharmacal Research, 2012, 35 : 1055 - 1064
  • [40] Effects of Furanocoumarins in Kampo Extract-Based Medicines on Rat Intestinal Absorption of CYP3A and P-glycoprotein Substrate Drugs In Vivo
    Iwanaga, Kazunori
    Arimune, Kaori
    Miyazaki, Makoto
    Shibano, Makio
    Taniguchi, Masahiko
    Baba, Kimiye
    Kakemi, Masawo
    ARCHIVES OF PHARMACAL RESEARCH, 2012, 35 (06) : 1055 - 1064
12345